Citius Oncology Inc.

CTOR | NASDAQ | 0 Sledující

$1.53

-4.38%

-$0.07

Sledovat

Overview Metrics Financials

Breakdown	9/30/2024 USD	9/30/2023 USD	9/30/2022 USD	12/31/2021 USD
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	0 -	0 -	0 -	0 -
Gross profit	0 -	0 -	0 -	0 -
Operating expense	20,573 +69.72%	12,121 +149.58%	4,857 -	0 -
Operating income	-20,573 -69.72%	-12,121 -149.58%	-4,857 -	0 -
Pretax Income	-20,573 -69.72%	-12,121 -149.58%	-4,857 -47,923.33%	-10 -
Tax Provision	576 0.00%	576 0.00%	576 -	0 -
Net income	-21,149 -66.56%	-12,697 -133.72%	-5,433 -53,618.97%	-10 -
EPS	-0.3 +78.87%	-1.42 -136.67%	-0.6 -49,900.00%	-0 -
Diluted EPS	-0.3 +78.87%	-1.42 -136.67%	-0.6 -49,900.00%	-0 -
Average Shares	71,552 -20.04%	89,480 -0.75%	90,160 +10.76%	81,400 -
Diluted Average Shares	71,552 -20.04%	89,480 -0.75%	90,160 +10.76%	81,400 -
EBIT	-20,573 -69.72%	-12,121 -149.58%	-4,857 -47,937.58%	-10 -
EBITDA	-20,573 -69.72%	-12,121 -149.58%	-4,857 -47,937.58%	-10 -

Soubory cookie používáme ke zlepšení prohlížení na webu.